Table 2. Summary of clinical, laboratory, and imaging characteristics, as well as information about the need for oxygen therapy.
| Xu et al. 25 | Cai et al. 26 | Su et al. 27 | Du et al. 28 | Tan et al. 14 | Garazzino et al. 15 | |
|---|---|---|---|---|---|---|
| Number of children | 10 | 10 | 9 | 14 | 10 | 168 |
| Age group (years) | 0-15 | 0-10 | 0-9 | 0-16 | 1-12 | 0-17 |
| Male/female | 5/5 | 4/6 | 3/6 | 6/8 | 3/7 | 94/74 |
| Location | China | China | China | China | China | Italy |
| Period |
|
|
|
|
|
|
| Fever | 7 (70%) | 8 (80%) | 2 (22.2%) | 5 (35.7%) | 4 (40%) | 138 (82.1%) |
| Cough | 5 (50%) | 6 (60%) | 1 (11.1%) | 3 (21.4%) | 3 (30%) | 82 (48.8%) |
| Myalgia/fatigue | --- | --- | --- | --- | 3 (1.8%) | |
| Diarrhea, nausea, and/or vomiting | 3 (30%) | 0 | --- | --- | 1 (10%) | 22 (13.1%) |
| Odynophagia | 4 (40%) | 4 (40%) | --- | --- | --- | 9 (5.4%) |
| Dyspnea/tachypnea | --- | 0 | --- | --- | --- | 16 (9.5%) |
| Abnormality on chest CT | 5 (50%) | 4 (40%) | --- | 6 (42.8%) | 5 (50%) | --- |
| Leukocytosis | --- | 3 (30%) | --- | --- | 1 (10%) | --- |
| Neutropenia | 2 (20%) | 3 (30%) | --- | --- | 0 | --- |
| Lymphocytosis | 3 (30%) | 1 (10%) | --- | --- | 0 | --- |
| Lymphopenia | 3 (30%) | 0 | --- | --- | 0 | --- |
| Leukopenia | 1 (30%) | 1 (10%) | --- | --- | 0 | --- |
| Increased AST and ALT | 1 (10%) | 2 (20%) | 0 | --- | --- | --- |
| Increased CK/CK-MB | 0 | 5 (50%) | 6 (66.6%) | --- | --- | --- |
| Increased CRP | 3 (30%) | 3 (30%) | 0 | --- | --- | 47/121 (38.8%) |
| Increased procalcitonin | 5 (50%) | 0 | --- | --- | --- | --- |
| Increased ESR | 3 (30%) | --- | 0 | --- | --- | --- |
| Need for oxygen | 0 | 0 | 0 | 0 | 0 | --- |
CT: computed tomography; AST: aspartate transaminase; ALT: alanine transaminase; CK: creatine kinase: CK-MB: CK MB isoenzyme; CRP: C-reactive protein; ESR: erythrocyte sedimentation rate.